Medicare Enrolled
Dr. Naim Alkhouri, MD
Internal Medicine · Westlake, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Alkhouri from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alkhouri?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Alkhouri
Dr. Naim Alkhouri is an internal medicine specialist in Westlake, OH, with 19 years of NPI registration. Based on federal Medicare data, Dr. Alkhouri performed 1,460 Medicare services across 786 unique beneficiaries.
Between the years covered by Open Payments, Dr. Alkhouri received a total of $1,357,154 from 57 pharmaceutical and/or device companies across 1118 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Alkhouri is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 15% volume in OH
$1,357,154 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,460
Medicare services
Top 15% in OH for internal medicine
786
Unique beneficiaries
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~77 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
252 | $87 | $221 |
| Ultrasound scan of organ tissue for measuring elasticity This procedure uses ultrasound technology to assess the stiffness or elasticity of organ tissues. It helps evaluate tissue characteristics without invasive methods. |
187 | $74 | $298 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
165 | $35 | $66 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
139 | $29 | $54 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
115 | $6 | $6 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
103 | $34 | $64 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
93 | $30 | $41 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
83 | $114 | $330 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
83 | $35 | $71 |
| Additional chronic care management time, 60 minutes This service covers an additional 60 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions, billed per calendar month. |
73 | $51 | $96 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
56 | $63 | $161 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
52 | $95 | $181 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
25 | $14 | $24 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
20 | $126 | $291 |
| New patient office visit, complex (60-74 min) | 14 | $147 | $415 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$1,357,154
Total received (2018-2024)
Avg $193,879/year across 7 years
Top 0% in OH for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
1,118
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$862,209 (63.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$453,649 (33.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$41,296 (3.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$313,875
2023
$307,572
2022
$248,481
2021
$84,282
2020
$69,134
2019
$230,527
2018
$103,282
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Ipsen Biopharmaceuticals, Inc
$92,852
Madrigal Pharmaceuticals
$80,264
Gilead Sciences, Inc.
$37,644
Boehringer Ingelheim International GmbH
$34,119
Novo Nordisk Inc
$15,055
Alexion Pharmaceuticals, Inc.
$13,680
ABBVIE INC.
$13,388
Intercept Pharmaceuticals, Inc.
$11,625
Merck Sharp & Dohme LLC
$7,861
Echosens North America, Inc.
$4,073
Novo Nordisk AS
$1,190
GlaxoSmithKline, LLC.
$800
PFIZER INC.
$600
Regeneron Pharmaceuticals, Inc.
$189
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$151
Boehringer Ingelheim Pharmaceuticals, Inc.
$102
FUJIFILM Healthcare Americas Corporation
$100
HISTOSONICS,INC.
$59
ORPHALAN INC
$56
Takeda Pharmaceuticals U.S.A., Inc.
$27
Mirum Pharmaceuticals, Inc.
$22
Braintree Laboratories, Inc.
$20
Top 3 companies account for 67.1% of 2024 payments
All-time payments by company (2018-2024) ›
Perspectum Diagnostics Ltd
$210,807
Gilead Sciences, Inc.
$153,598
Intercept Pharmaceuticals, Inc.
$134,020
Ipsen Biopharmaceuticals, Inc
$111,395
Shionogi Inc
$84,802
Madrigal Pharmaceuticals
$80,264
Alexion Pharmaceuticals, Inc.
$74,470
Novo Nordisk Inc
$64,001
Boehringer Ingelheim International GmbH
$57,510
Echosens North America, Inc.
$42,047
AbbVie, Inc.
$35,881
INTERCEPT PHARMACEUTICALS, INC.
$35,373
EISAI INC.
$33,146
Novo Nordisk AS
$32,071
ABBVIE INC.
$28,160
AbbVie Inc.
$20,601
PFIZER INC.
$19,882
Eisai Inc.
$19,520
Exelixis Inc.
$18,668
Merck Sharp & Dohme LLC
$15,877
Dova Pharmaceuticals
$15,464
Siemens Medical Solutions USA, Inc.
$14,154
ALBIREO PHARMA, INC.
$13,362
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$12,348
Boehringer Ingelheim Pharmaceuticals, Inc.
$10,258
Theratechnologies Inc.
$8,553
W. L. Gore & Associates, Inc.
$2,393
Takeda Pharmaceuticals U.S.A., Inc.
$1,827
VBI Vaccines (Delaware) Inc.
$1,810
Allergan Inc.
$1,649
GlaxoSmithKline, LLC.
$800
Cook Medical LLC
$520
Regeneron Pharmaceuticals, Inc.
$189
Boston Scientific Corporation
$185
Sysmex America, Inc.
$179
Amicus Therapeutics, Inc.
$140
Prometheus Laboratories Inc.
$137
Lilly USA, LLC
$125
Merck Sharp & Dohme Corporation
$123
Sirtex Medical Inc
$107
FUJIFILM Healthcare Americas Corporation
$100
Mirum Pharmaceuticals, Inc.
$83
ORPHALAN INC
$80
Bayer HealthCare Pharmaceuticals Inc.
$67
Travere Therapeutics, Inc.
$65
HISTOSONICS,INC.
$59
La Jolla Pharmaceutical Company
$59
Intra-Sana Laboratories
$46
Janssen Biotech, Inc.
$36
Grifols USA, LLC
$22
Alnylam Pharmaceuticals Inc.
$20
Braintree Laboratories, Inc.
$20
Retrophin, Inc.
$19
Nestle HealthCare Nutrition Inc.
$19
BOSTON SCIENTIFIC CORPORATION
$16
Evoke Pharma, Inc.
$15
Amgen Inc.
$13
Top 3 companies account for 36.7% of all-time payments
Associated products mentioned in payments ›
(820) Cholbam · ADVIA Centaur XP Analyzer · ADVIA Chemistry XPT System · AMJEVITA · Albutein · Bylvay · CARESPHERE WORKFLOW SOLUTION · CUVRIOR · Cabometyx · Cholbam · Doptelet · ECHOTIP · EGRIFTA · ENTYVIO · Epclusa · FibroScan · GALAFOLD · GENERAL PAIN MANAGEMENT · GIMOTI · GIVLAARI · GLYCATE · GORE CARDIOFORM Septal Occluder · GORE VIATORR TIPS Endoprosthesis · Halaven · IQIRVO · KANUMA · KEYTRUDA · Kanuma · LENVIMA · LINZESS · Lenvima · Livdelzi · LiverMultiScan · Livmarli · MAVYRET · Mavyret · Mulpleta · Nexavar · OCALIVA · PreHevbrio · RELTONE 200 MG · REMICADE · RESMETIROM · REZDIFFRA · SIR-Spheres Microspheres · STELARA · SUTAB · Stivarga · Strensiq · TRULANCE · TheraSphere Y90 Glass Microspheres 10 GBq · UTASWAKO AFP-L3 · Wegovy · XIFAXAN · XN Series · ZENPEP · ZEPATIER
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (64%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for internal medicine in OH.
Geographic Context
Internal medicine physicians within 10 mi
1,108
Per 100K population
88.7
County median income
$62,823
Nearest hospital
UH ST JOHN MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Alkhouri is a clinical cardiology specialist, with above-average Medicare volume (top 15% in OH), with speaking/promotional industry engagement in the top 0% of OH peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Alkhouri experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Alkhouri performed 252 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alkhouri receive payments from pharmaceutical companies?
Yes. Dr. Alkhouri received a total of $1,357,154 from 57 companies across 1,118 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alkhouri's costs compare to other internal medicine physicians in Westlake?
Dr. Alkhouri's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alkhouri) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Westlake
Browse internal medicine physicians in Westlake ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in OH
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in OH
Which OH internal medicine physicians receive the most from drug and device companies.
By company
Perspectum Diagnostics Ltd Payments to Doctors
See all physicians who received payments from Perspectum Diagnostics Ltd.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
Intercept Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Intercept Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology